IGC Pharma (IGC) Accumulated Expenses (2011 - 2026)
IGC Pharma (IGC) reported Accumulated Expenses of $892000.0 for Q1 2026, down 35.08% year-over-year from $1.4 million in Q1 2025, and down 7.28% quarter-over-quarter from $962000.0 in Q4 2025.
IGC Pharma (IGC) Accumulated Expenses (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has 13 years of Accumulated Expenses data on file, last reported at $892000.0 in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $892000.0, down 35.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $892000.0 (down 35.08% YoY), and the FY2026 annual result was $892000.0, down 35.08% from the prior year.
- Accumulated Expenses fell to $892000.0 in Q1 2026 per IGC's latest filing, from $962000.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $1.6 million in Q1 2024 and troughed at $191000.0 in Q2 2025.
- A 4-year average of $995454.5 and a median of $1.0 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses climbed 14.55% in 2024, then tumbled 81.13% in 2025.
- A 4-year view of Accumulated Expenses shows it stood at $1.3 million in 2023, then tumbled by 32.92% to $864000.0 in 2024, then gained by 11.34% to $962000.0 in 2025, then declined by 7.28% to $892000.0 in 2026.
- Business Quant data shows IGC's Accumulated Expenses at $892000.0 in Q1 2026, $962000.0 in Q4 2025, and $398000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 892,000.00 |
| Dec 31, 2025 | 962,000.00 |
| Sep 30, 2025 | 398,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 864,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2019 | 652,000.00 |
| Sep 30, 2019 | 677,000.00 |
| Jun 30, 2019 | 452,000.00 |
| Mar 31, 2019 | 509,000.00 |
| Sep 30, 2018 | 453,000.00 |
| Jun 30, 2018 | 148,947.00 |
| Mar 31, 2018 | 204,000.00 |
| Dec 31, 2017 | 457,757.00 |
| Sep 30, 2017 | 197,716.00 |